Media Release
Ajman, Nov 28: Gulf Medical University (GMU), a leading medical university in the Middle East region signed an agreement of collaboration with Ain Shams University (ASU), one of Egypt’s leading universities, which seeks to establish and strengthen academic and research cooperation.
The agreement was signed at GMU on November 26, by Prof Hossam Hamdy, chancellor of GMU and Prof Dr Mahmoud El-Metini, president and chairman of ASU, on behalf of the respective universities. Under the agreement, both the universities will facilitate academic exchanges as well as student/faculty exchanges and undertake joint research and training programmes.
Prof Hossam Hamdy said that GMU’s collaboration with ASU was a milestone for the university and both their respective countries. “ASU is a leading university by all standards, in Egypt and the region, be it in the field of academia or research. The collaboration between both the universities will open a new world of opportunities in healthcare and research, benefiting both our countries and the region, in the long run.”
Commenting on his visit to GMU, Prof Dr Mahmoud El-Metini said he was 'amazed and impressed' by the academic and research facilities at the university and the academic hospitals in the campus. “ASU is glad to partner with GMU. The potential of this collaboration is huge and both the universities stand to benefit a lot in terms of student and faculty exchanges and research cooperation. We hope to develop this collaboration into a full-fledged partnership, in the future.”
Gulf Medical University has been establishing tie-ups with leading international universities and research institutions in the United States, Europe, China, India, Japan, Korea, the Gulf States and the Arab Republic of Egypt, in line with its strategic directions. In the field of research, the university has established international research laboratories that cooperate with a large number of international research centers and work with their counterparts in the UAE, especially in the field of immunology research to treat cancer.